Micro-Tech (Nanjing) Co., Ltd. is mainly engaged in the R&D, manufacturing and sales of minimally invasive medical devices. In line with our mission of “supporting clinicians with technology and innovation,”Micro-Tech is committed to providing high-quality products and services to hospitals and clinics around the world, advancing the quality of care, improving patient outcome and maintaining low costs. After 20 years of innovation-driven development, Micro-Tech has extended its product family from non-vascular stents to three major product platforms, namely, endoscopic diagnostic instruments and consumables, tumor ablation instruments and consumables, and endoscopic optical coherence tomography (EOCT). Further, Micro-Tech has expanded our market presence from China to over 70 other countries around the world. Micro-Tech has become a leading company in the field of minimally invasive medical technology through scientific research and innovation, competitive advantage in core products and rapid growth in market share. Micro-Tech has a stable, high-caliber, international and interdisciplinary technical team with expertise in biomedical engineering, chemical engineering, mechanical engineering, automation and computer sciences, providing a strong foundation for the company’s constant innovation. Micro-Tech has won three national awards including runner-up for the National Prize for Progress in Science and Technology, and 12 provincial and ministerial awards. Further, Micro-Tech has 36 domestic and foreign invention patents, 74 domestic Class II and Class III registration certificates, 35 U.S. FDA cleared devices, and 36 European CE certificates. As of the end of 2018, Micro-Tech achieved an operating income of RMB 922 million and a net profit of RMB 203 million. From 2016 to 2018, the compound annual growth rate of sales revenue stood at 49.19%, much higher than other competitors in the industry .